EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Pharma’s innovation ROI: Gains made, challenges ahead

The biopharmaceutical industry’s return on investment in innovation is increasing, but R&D costs are rising, according to a new Deloitte report.

VPAG hikes put UK life sciences at risk, warns pharma

The industry already contributes more than £17.6 billion directly to the UK economy, but it believes that growth has stagnated because of VPAG.

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.
Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
Hand with vaccine

UK Chikungunya vaccine approval in sight for Bavarian Nordic

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.
Handshake on a green background

Jazz Pharmaceuticals to acquire Chimerix in $935m deal

In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing oncology therapies.